GSK Prodded Toward Mediation In Avandia MDL

Law360, New York (November 8, 2011, 10:15 PM EST) -- Less than a week after GlaxoSmithKline PLC paid $3 billion to settle U.S. government probes into, among other practices, its marketing of Avandia, a Pennsylvania federal judge on Monday pushed the drugmaker toward mediation with plaintiffs in multidistrict litigation over the controversial diabetes drug.

U.S. District Judge Cynthia M. Rufe stayed the MDL and gave the parties 75 days to resolve at least 85 percent of the cases, which allege that GSK concealed the diabetes medications' potential to cause heart attack and stroke in some patients....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.